The Effects of Allicor on Patients After Revascularization Treatment During a Year

NCT05813171 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

300

Enrollment

OTHER

Sponsor class

Conditions

Atherosclerosis
Peripheral Arterial Disease

Interventions

DIETARY_SUPPLEMENT: Allicor
DRUG: Placebo

Sponsor

Institute for Atherosclerosis Research, Russia